Loading clinical trials...

PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDPhase 2NCT03837457

PRISM: Efficacy and Safety of Cobomarsen (MRG-106) in Subjects With Mycosis Fungoides Who Have Completed the SOLAR Study

The main objective of this clinical trial is to study the efficacy and safety of cobomarsen (also known as MRG-106) for the treatment of cutaneous T-cell lymphoma (CTCL), mycosis fungoides (MF) subtyp...

Lead sponsor: miRagen Therapeutics, Inc.•5 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITING

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma

NCT06588868 · Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, and more

COMPLETED

Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

NCT06113081 · Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, and more

COMPLETEDPhase 2

PK and ECG Determinations Following 8 Weeks of HyBryte Treatment for Cutaneous T-Cell Lymphoma

NCT05380635 · Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 19, 2020Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment8

Start dateOct 2019

Last updatedNov 19, 2020

Condition

Cutaneous T-Cell Lymphoma/Mycosis Fungoides

Locations shown

Mayo Clinic Hospital

Phoenix, Arizona

Dana-Farber Cancer Institute

Boston, Massachusetts

Washington University School of Medicine

St Louis, Missouri

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 19, 2020Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions